Literature DB >> 2952726

Human Fc gamma receptors: stable inter-donor variation in quantitative expression on platelets correlates with functional responses.

S I Rosenfeld, D H Ryan, R J Looney, C L Anderson, G N Abraham, J P Leddy.   

Abstract

Evidence has recently been presented that a 40,000 dalton membrane sialoglycoprotein (p40) shared by monocytes and granulocytes serves as the human platelet receptor for aggregated IgG. We now report that the platelets of normal donors exhibit stable quantitative differences in the expression of this receptor molecule, as determined by flow cytometry using fluorescent staining with murine monoclonal antibody to p40 (mab IV.3). These inter-donor differences were reproducible on repeated testing over at least 4 mo. In concurrent assays, the binding of mab IV.3 to each donor's platelets was highly correlated with the binding of heat-aggregated human IgG, also assayed by flow cytometry. The biological relevance of this quantitative variation in IV.3 binding is suggested by its reproducible correlation with platelet responsiveness to aggregated IgG measured by aggregometry. Such stable quantitative variation in platelet Fc receptor expression among individual humans could contribute to differences in severity of certain pathologic processes initiated by IgG-containing immune complexes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952726

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Function and heterogeneity of human Fc receptors for immunoglobulin G.

Authors:  J C Unkeless
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  The polymorphic Fc gamma receptor II gene maps to human chromosome 1q.

Authors:  H O Grundy; G Peltz; K W Moore; M S Golbus; L G Jackson; R V Lebo
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.

Authors:  U P Naik; Y H Ehrlich; E Kornecki
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

4.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 5.  Functional capacity of Fc gamma receptor III (CD16) on human neutrophils.

Authors:  J C Edberg; J E Salmon; R P Kimberly
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

6.  Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors.

Authors:  M R Walker; J Lund; K M Thompson; R Jefferis
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

7.  In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

Authors:  R P Kimberly; J C Edberg; L T Merriam; S B Clarkson; J C Unkeless; R P Taylor
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

8.  Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

Authors:  Cunji Gao; Brian Boylan; Dan Bougie; Joan C Gill; Jessica Birenbaum; Debra K Newman; Richard H Aster; Peter J Newman
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

9.  Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.

Authors:  Leigh Naylor-Adamson; Anisha R Chacko; Zoe Booth; Stefano Caserta; Jenna Jarvis; Sujoy Khan; Simon P Hart; Francisco Rivero; David J Allsup; Mònica Arman
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

10.  Differential susceptibility and response of primary human myeloid BDCA1(+) dendritic cells to infection with different Enteroviruses.

Authors:  Barbara M Schulte; Esther D Kers-Rebel; Amy C Prosser; Jochem M D Galama; Frank J M van Kuppeveld; Gosse J Adema
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.